Is There a Long-Term Benefit to use Patient-Specific Guides for Glenoid Implant Positioning in aTSA? A comparative study at minimum 10 years.

J Shoulder Elbow Surg · Jun 24 2026 · Recent

Gauci MO, Millet N, Jacquot A, Berhouet J, Bronsard N, Gonzalez JF, et al.

IULS-Institut Universitaire Locomoteur et Sports, Pasteur 2 Hospital, CHU, France

Shoulder & Elbow

SUMMARY — THE REDUCTIONIn a 10-year comparative study, patient-specific guides for glenoid positioning in anatomic TSA showed no clinical, functional, or revision-rate advantage over standard instrumentation.
Abstract, as published

BACKGROUND: The efficacy of patient-specific guides (PSGs) in improving accuracy and reducing the number of outliers in glenoid implant positioning in anatomic total shoulder arthroplasty has been clearly shown. However, long-term clinical benefit in terms of outcomes, revision rates and patient satisfaction remains unproven. Our purpose was to compare the long-term clinical and radiographic outcomes of two aTSA groups, with or without the use of a PSG for glenoid implant positioning.

METHODS: A retrospective comparative study based on a prospective cohort was conducted including all patients with aTSA Tornier Perform Anatomic Glenoid (Stryker, Kalamazoo, MI) performed between January 2013 and May 2015 at a minimum 10 years of follow-up (FU). Patients were divided into two groups based on the use of a 3D preoperative planning and PSG (PSG Vs no-PSG group) generated by Glenosys (Imascap, Plouzané, France). Forty-seven patients (27 in the no-PSG and 20 in the PSG group) were included. The last-FU radiographic and clinical outcomes were evaluated.

RESULTS: One patient was revised to a reverse shoulder arthroplasty in each group (p>0.999) for glenoid loosening. There was no difference in terms of Visual Analogue Score (1±2 Vs 1±1 ;p=0.254), Subjective Shoulder Value (85±15 Vs. 87±14 ;p=0.592), the rate of satisfaction (4: 73%; 3: 23%; 2: 4% Vs 4: 79% ; 3: 16%; 2: 5% ;p= 0.856), active anterior elevation (153±21° Vs 163±11°; p=0.148), passive anterior elevation (155±20° Vs 167±9° ;p=0.1), active external rotation (54±18° Vs 56±8° ;p=0.809) active internal rotation (7±3 Vs 7±2 ;p= 0.706), and adjusted Constant Murley Score (118±21 Vs 123±14 ;p= 0.76). Furthermore, no significant difference in terms of Mole's mean score (5±7 ;p=0.686) and in the rate of component migration (19% Vs 20% ;p= 0.999) was observed.

CONCLUSION: PSG systems for glenoid implants in aTSA show no improvement (revision and function) over 10 years of FU compared to the non-PSG method, indicating that PSG systems may not be necessary. The true benefits may lie in other areas that have not yet been sufficiently explored deserving specific evaluation.

Featured in the 2026-07-25 issue.

← Progressive Understanding of Cord, Capsule, and Cable Functio…Do Personalized Recovery Trajectories Enhance the Utility of … →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.